Fentanyl REMS May Need Better Surveillance Methods Before Possible Modifications

Sponsors currently use sources such as spontaneous adverse event reports to assess whether REMS for immediate-release fentanyl products is achieving its purpose, although such methods are limited in their ability to portray a clear picture.